Taiwan Liposome Company, Ltd.
CIK 0001722890
Revenue (TTM)
3.63M
−48.1% YoY
FY Dec 2020
Net Income (TTM)
−35.02M
−29.7% YoY
FY Dec 2020
EPS Diluted (TTM)
−0.44
−207.3% YoY
FY Dec 2020
Gross Margin
—
FY Dec 2020
Operating Margin
-964.5%
FY Dec 2020
Net Margin
-964.7%
FY Dec 2020
Free Cash Flow (TTM)
—
FY Dec 2020
Cash
47.82M
FY Dec 2020
Total Debt
—
FY Dec 2020
Shares Outstanding
84.15M sh
FY Dec 2020